BioSpace News Archive

Arthur Tzianabos, Ph.D. has extensive experience in the development and commercialization of rare disease treatments

Mackay brings a wealth of relevant experience to Satellos, with specific senior business background in regenerative bioscience.

AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced updated topline clinical results for its ongoing single-patient expanded access program

tarting this fall, physical therapists and physical therapist assistants can meet their 2018 CEU deadline by registering for these courses directly through the Education Resources Inc. website:

Distinguished Ophthalmology Specialist Brings Wealth of Experience

FSD has now joined some of the largest licensed producers in Canada that currently use the CMRC and the technology solutions provided by Snipp.

Today, the Huggies® No Baby Unhugged program is awarding seven $10,000 grants to help support or establish volunteer hugging programs in hospitals across the country.

Concussion symptoms for children under 13 years old typically last three times longer than they do for older teens and adults, but keeping them out of the classroom during recovery is not necessarily the preferred treatment, according to a comprehensive research review in The Journal of the American Osteopathic Association.

WAT Medical’s innovative technology to treat all primary headaches, HeadaTerm, received its FDA clearance in September 2018.

Huami Corporation (“Huami” or the “Company”) (NYSE:HMI), a biometric and activity data-driven company with significant expertise in smart wearable technology, today announced the launch of the Amazfit Verge - the Amazfit smart watch, that brings new, customizable features to the smart wearables industry.